Management of Thyroid Eye Disease: A Comparison Between Three Recent Clinical Guidelines
Rapid advances in the diagnosis and treatment of thyroid eye disease (TED) have led to the development of three patient care guidelines by regional professional societies: the European Group on Graves' Orbitopathy, the Oculoplastics and Orbital Diseases Group of the Chinese Medical Association Ophthalmology Branch/Thyroid Group of the Chinese Medical Association Endocrinology Branch, and the American Thyroid Association/European Thyroid Association. Although broad consensus can be found across the three guidelines, important differences could affect patient management. This review examines and compares the recommendations of these guidelines across 11 dimensions, from disease diagnosis to treatment strategies. We explore the possible root sources of these variations. The review also suggests future directions and potential implications, thus providing a comprehensive perspective of current and future management of TED.
Authors
- Kelvin Kam Lung Chong (ORCID: https://orcid.org/0000-0003-2587-1323)
- Runchuan Li (ORCID: https://orcid.org/0000-0002-1921-0281)
- Chaoyu Lei (ORCID: https://orcid.org/0009-0002-8776-8743)
- Huifang Zhou (ORCID: https://orcid.org/0009-0004-2199-3854)
- Jun Jin (ORCID: https://orcid.org/0000-0001-8319-5330)
- Chee Chew Yip
- Terry J Smith
- Jing Sun
Institutions
- Chinese University of Hong Kong (HK)
- University of Michigan (US)
- Hong Kong Eye Hospital (CN)
- Khoo Teck Puat Hospital (SG)
- Shanghai Ninth People's Hospital (CN)
- Prince of Wales Hospital (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- Ophthalmology and Therapy
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1007/s40123-026-01326-z
- Primary Topic
- Ophthalmology and Eye Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Shanghai Jiao Tong University